Barclays
CABA icon

Barclays’s Cabaletta Bio CABA Stock Holding History

Barclays’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$139K Sell
44,701
-53,091
-54% -$175K ﹤0.01% 3901
2026
Q1 		$263K Sell
97,792
-122,904
-56% -$341K ﹤0.01% 3538
2025
Q4 		$483K Buy
220,696
+217,613
+7,058% +$539K ﹤0.01% 3866
2025
Q3 		$7.21K Sell
3,083
-6,654
-68% -$11.4K ﹤0.01% 5049
2025
Q2 		$14.8K Sell
9,737
-46,701
-83% -$72.8K ﹤0.01% 4878
2025
Q1 		$78.2K Sell
56,438
-15,179
-21% -$32.3K ﹤0.01% 4479
2024
Q4 		$163K Buy
71,617
+10,487
+17% +$36.8K ﹤0.01% 4399
2024
Q3 		$289K Buy
61,130
+19,891
+48% +$115K ﹤0.01% 4110
2024
Q2 		$308K Sell
41,239
-7,729
-16% -$94.7K ﹤0.01% 3330
2024
Q1 		$835K Sell
48,968
-80,104
-62% -$1.72M ﹤0.01% 3257
2023
Q4 		$2.93M Buy
129,072
+64,486
+100% +$1.08M ﹤0.01% 2587
2023
Q3 		$983K Buy
64,586
+59,490
+1,167% +$813K ﹤0.01% 2352
2023
Q2 		$65.8K Sell
5,096
-62,102
-92% -$674K ﹤0.01% 3720
2023
Q1 		$556K Buy
67,198
+63,052
+1,521% +$590K ﹤0.01% 3191
2022
Q4 		$38.4K Buy
4,146
+2,925
+240% +$10.7K ﹤0.01% 4639
2022
Q3 		$1K Sell
1,221
-13,942
-92% -$16.8K ﹤0.01% 4678
2022
Q2 		$16K Sell
15,163
-556
-4% -$786 ﹤0.01% 4478
2022
Q1 		$32K Buy
+15,719
New +$41.1K ﹤0.01% 4282

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Barclays's CABA Position: Q2 2026 in Review

Barclays reduced its Cabaletta Bio (CABA) stake by 54% in Q2 2026, selling an estimated $175K and leaving 44,701 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #3901.

Barclays first reported a position in CABA in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.93M in Q4 2023. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Barclays held 44,701 shares of Cabaletta Bio worth $139K as of Q2 2026.
  • Barclays sold 53,091 Cabaletta Bio shares in Q2 2026, an estimated $175K.
  • Cabaletta Bio made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3901 holding.
  • Barclays first reported a position in Cabaletta Bio in Q1 2022 and has held it in 18 quarters since.
  • Barclays's Cabaletta Bio position peaked at $2.93M in Q4 2023.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.